The treatment of late luteal phase dysphoric disorder.
This mini-review provides a comprehensive discussion of the management of the late luteal phase dysphoric disorder (LLPDD). The various treatments will be described with particular attention to their efficacy and the nature of side effects. These include: psychoactive drugs (lithium, anxiolytics, antidepressants), nutritional agents (L-tryptophan, Vitamin B6, prostaglandins precursors and inhibitors), dopamine agonists, diuretics, antihypertensives, hormonal interventions (gonadotrophin releasing hormone analogues, oestradiol, tamoxifen, progesterone, danazol, and oral contraceptives). Less attention has been given to non-pharmacologic approaches such as diet, exercise and psychotherapy. The availability of an operational definition of LLPDD in the DSM-III-R and the improvement in research methodology has provided a clearer direction for clinical management and for future investigations.
Steinberg
S
S
St. Mary's Hospital Centre, Montreal, Quebec, Canada.
D015444:Exercise; D005260:Female; D006728:Hormones / Q000627:therapeutic use; D006801:Humans; D008183:Luteal Phase; D011293:Premenstrual Syndrome / Q000503:physiopathology / Q000628:therapy*; D011613:Psychotherapy
D006728:Hormones